Suppr超能文献

干扰素刺激基因 15 和蛋白质 ISGylation 系统。

Interferon-stimulated gene 15 and the protein ISGylation system.

机构信息

Sanford-Burnham Medical Research Institute, La Jolla, California, USA.

出版信息

J Interferon Cytokine Res. 2011 Jan;31(1):119-30. doi: 10.1089/jir.2010.0110. Epub 2010 Dec 29.

Abstract

Interferon-stimulated gene 15 (ISG15) is one of the most upregulated genes upon Type I interferon treatment or pathogen infection. Its 17  kDa protein product, ISG15, was the first ubiquitin-like modifier identified, and is similar to a ubiquitin linear dimer. As ISG15 modifies proteins in a similar manner to ubiquitylation, protein conjugation by ISG15 is termed ISGylation. Some of the primary enzymes that promote ISGylation are also involved in ubiquitin conjugation. The process to remove ISG15 from its conjugated proteins, termed de-ISGylation, is performed by a cellular ISG15-specific protease, ubiquitin-specific proteases with molecular mass 43 kDa (UBP43)/ubiquitin-specific proteases 18. Relative to ubiquitin, the biological function of ISG15 is still poorly understood, but ISG15 appears to play important roles in various biological and cellular functions. Therefore, there is growing interest in ISG15, as the study of free ISG15 and functional consequences of ISGylation/de-ISGylation may identify useful therapeutic targets. This review highlights recent discoveries and remaining questions important to understanding the biological functions of ISG15.

摘要

干扰素刺激基因 15(ISG15)是 I 型干扰素治疗或病原体感染后上调最明显的基因之一。其 17kDa 的蛋白质产物 ISG15 是最早被鉴定的泛素样修饰物,类似于泛素的线性二聚体。由于 ISG15 以类似于泛素化的方式修饰蛋白质,因此 ISG15 对蛋白质的修饰被称为 ISG 化。一些促进 ISG 化的主要酶也参与泛素的连接。将 ISG15 从其连接的蛋白质上去除的过程,称为去 ISG 化,由细胞内 ISG15 特异性蛋白酶、分子量为 43kDa 的泛素特异性蛋白酶 43(UBP43)/泛素特异性蛋白酶 18 完成。与泛素相比,ISG15 的生物学功能仍知之甚少,但 ISG15 似乎在各种生物学和细胞功能中发挥重要作用。因此,人们对 ISG15 的兴趣日益浓厚,因为研究游离 ISG15 和 ISG 化/去 ISG 化的功能后果可能会确定有用的治疗靶点。这篇综述强调了最近的发现和对理解 ISG15 生物学功能仍很重要的问题。

相似文献

1
Interferon-stimulated gene 15 and the protein ISGylation system.
J Interferon Cytokine Res. 2011 Jan;31(1):119-30. doi: 10.1089/jir.2010.0110. Epub 2010 Dec 29.
2
Molecular Pathways of Interferon-Stimulated Gene 15: Implications in Cancer.
Curr Protein Pept Sci. 2021;22(1):19-28. doi: 10.2174/1389203721999201208200747.
3
Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation.
Mol Cell Biol. 2004 Nov;24(21):9592-600. doi: 10.1128/MCB.24.21.9592-9600.2004.
4
The ISG15/USP18 ubiquitin-like pathway (ISGylation system) in hepatitis C virus infection and resistance to interferon therapy.
Int J Biochem Cell Biol. 2011 Oct;43(10):1427-31. doi: 10.1016/j.biocel.2011.06.006. Epub 2011 Jun 16.
5
A negative feedback of the HIF-1α pathway via interferon-stimulated gene 15 and ISGylation.
Clin Cancer Res. 2013 Nov 1;19(21):5927-39. doi: 10.1158/1078-0432.CCR-13-0018. Epub 2013 Sep 20.
6
An Approach for the Identification of Proteins Modified with ISG15.
Methods Mol Biol. 2019;1934:235-246. doi: 10.1007/978-1-4939-9055-9_15.
7
ISG15 in cancer: Beyond ubiquitin-like protein.
Cancer Lett. 2018 Dec 1;438:52-62. doi: 10.1016/j.canlet.2018.09.007. Epub 2018 Sep 11.
8
The Functional Roles of ISG15/ISGylation in Cancer.
Molecules. 2023 Jan 31;28(3):1337. doi: 10.3390/molecules28031337.
9
ISG15: a ubiquitin-like enigma.
Front Biosci. 2005 Sep 1;10:2701-22. doi: 10.2741/1730.
10
The diverse repertoire of ISG15: more intricate than initially thought.
Exp Mol Med. 2022 Nov;54(11):1779-1792. doi: 10.1038/s12276-022-00872-3. Epub 2022 Nov 1.

引用本文的文献

2
is a -acting long noncoding RNA that enhances the host interferon response in human epithelial cells.
bioRxiv. 2025 Aug 22:2025.08.18.670784. doi: 10.1101/2025.08.18.670784.
4
Ubiquitin-like Proteins in Autoimmune Diseases: Current Evidence and Therapeutic Opportunities.
Immune Netw. 2025 May 1;25(3):e21. doi: 10.4110/in.2025.25.e21. eCollection 2025 Jun.
7
Interferon-Stimulated Genes: Novel Targets in Renal Pathogenesis.
Kidney Dis (Basel). 2025 May 2;11(1):390-401. doi: 10.1159/000546141. eCollection 2025 Jan-Dec.
9
The intestinal interferon system and specialized enterocytes as putative drivers of HIV latency.
Front Immunol. 2025 May 14;16:1589752. doi: 10.3389/fimmu.2025.1589752. eCollection 2025.
10

本文引用的文献

1
Hematopoietic cells from Ube1L-deficient mice exhibit an impaired proliferation defect under the stress of bone marrow transplantation.
Blood Cells Mol Dis. 2010 Aug 15;45(2):103-11. doi: 10.1016/j.bcmd.2010.05.009. Epub 2010 Jun 29.
3
Herc5 attenuates influenza A virus by catalyzing ISGylation of viral NS1 protein.
J Immunol. 2010 May 15;184(10):5777-90. doi: 10.4049/jimmunol.0903588. Epub 2010 Apr 12.
4
Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification.
Mol Cell Biol. 2010 May;30(10):2424-36. doi: 10.1128/MCB.01466-09. Epub 2010 Mar 22.
5
Species-specific antagonism of host ISGylation by the influenza B virus NS1 protein.
J Virol. 2010 May;84(10):5423-30. doi: 10.1128/JVI.02395-09. Epub 2010 Mar 10.
6
Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases.
J Virol. 2010 May;84(9):4619-29. doi: 10.1128/JVI.02406-09. Epub 2010 Feb 24.
7
The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process.
J Virol. 2010 May;84(9):4725-36. doi: 10.1128/JVI.02478-09. Epub 2010 Feb 17.
8
Telomere length regulates ISG15 expression in human cells.
Aging (Albany NY). 2009 Jul 17;1(7):608-21. doi: 10.18632/aging.100066.
9
ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells.
Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2253-8. doi: 10.1073/pnas.0909144107. Epub 2010 Jan 19.
10
ISG15 over-expression inhibits replication of the Japanese encephalitis virus in human medulloblastoma cells.
Antiviral Res. 2010 Mar;85(3):504-11. doi: 10.1016/j.antiviral.2009.12.007. Epub 2009 Dec 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验